The Board of Directors of Adimmune Corporation has authorized a buyback plan on November 11, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.65 TWD | -0.52% |
|
-0.17% | -13.57% |
May. 15 | Adimmune Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 28 | Adimmune Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-13.57% | 371M | |
+3.79% | 95.71B | |
+6.58% | 41.64B | |
-13.20% | 32.7B | |
+77.44% | 28.65B | |
-16.02% | 15.38B | |
-8.17% | 12.97B | |
-12.49% | 11.47B | |
+162.44% | 9.92B | |
-54.92% | 9.07B |
- Stock Market
- Equities
- 4142 Stock
- News Adimmune Corporation
- Adimmune Corporation authorizes a Buyback Plan.